Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 16/20 | 0.68 |
| ▸ | FNTB | P49356 | 16/20 | 0.68 |
| ▸ | PGGT1B | P53609 | 16/20 | 0.68 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7936099 | 0.99 | FNTA (0.67) | FNTAFNTBPGGT1BCHRM4CYP2C9 | |
| SCHEMBL7936009 | 0.83 | FNTA (0.72) | FNTAFNTBPGGT1B | |
| SCHEMBL7936002 | 0.83 | FNTA (0.72) | FNTAFNTBPGGT1B | |
| Hydrochloric Acid SCHEMBL7936095 | 0.83 | FNTA (0.72) | FNTAFNTBPGGT1B | |
| SCHEMBL7650227 | 0.81 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7655474 | 0.72 | FNTA (0.83) | FNTAFNTBPGGT1B | |
| SCHEMBL7465329 | 0.72 | FNTA (0.81) | FNTAFNTBPGGT1B | |
| SCHEMBL7528336 | 0.71 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7464345 | 0.71 | FNTA (0.81) | FNTAFNTBPGGT1B | |
| SCHEMBL7650231 | 0.69 | FNTA (0.60) | FNTAFNTBPGGT1BCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001017992-A1 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2001-03-15 | — | — | WO | disclosed |